Tamarac, FL, Jan. 13, 2016 (GLOBE NEWSWIRE) -- Leading nutritional supplement manufacturer IQ Formulations and its CEO Jay Cohen were the focus of a detailed feature piece recently published in Business View Magazine. The eight-page-long article in the publication’s January issue highlights Cohen’s vision of elevating the standards of the supplement industry when creating IQ Formulations in 2010, and the incredible success story that has followed.
“Cohen’s firm has been on an astonishing trajectory of growth since its inception, going from less than $124,000 in 2010 revenue, to 2015 sales of $20 million, today – a growth rate of 5,428 percent over the last three years,” the article states. But as the piece also notes, the CEO was set on doing things his own way, seeking to bring top-quality formulations to an industry that had lost sight of its true purpose.
The response was strong. As Cohen says in the article: “People welcomed it with open arms, because it was such a different philosophy, such a different product line. It brought integrity back into the industry. Our philosophy was to become a vertically integrated company that would put the research, the development, the manufacturing, and the production all under one roof. It was like a breath of fresh air.”
Customers were even willing to pay a premium for the products due to their superiority. “We felt consumers were ready for that,” Cohen continued. “They found that when they drank [our product], they felt better…felt healthier…lost weight and had more energy. It transformed that segment of the marketplace within a year.”
While the company continues to experience overwhelming consumer demand on an ongoing basis, CEO Jay Cohen is sure to regulate the growth to ensure optimum product quality and consistency – part of IQ Formulations’ key commitment to the customers it serves. Built upon a strong belief that it is their duty to help educate people about what they put into their bodies, the company seeks to elevate standards, not just for its own products, but for the supplement industry overall. IQ Formulations’ high-tech facilities, rigorous product testing and elite supplements, as well as its commitment to philanthropy, clearly demonstrate this mission of leading by example.
To read the full article in Business View Magazine, visit: https://www.businessviewmagazine.com/digital-magazines/jan-2016/#62
About IQ Formulations
IQ Formulations is one of the most highly regarded and fastest growing health and nutritional supplement companies in the U.S. Founded by industry veteran and IQ Formulations CEO Jay Cohen, IQ Formulations is headquartered in Tamarac, Florida. The company has become an industry leader known for its uncompromising commitment to professional facilities, top-quality products with amazing results, and superior customer service. Learn more at iqformulations.com.
Pamela Armstrong [email protected] 954-379-2115 x403


Robinhood Expands Sports Event Contracts With Player Performance Wagers
Amazon in Talks to Invest $10 Billion in OpenAI as AI Firm Eyes $1 Trillion IPO Valuation
Biren Technology Targets Hong Kong IPO to Raise $300 Million Amid China’s AI Chip Push
SUPERFORTUNE Launches AI-Powered Mobile App, Expanding Beyond Web3 Into $392 Billion Metaphysics Market
Treasury Wine Estates Shares Plunge on Earnings Warning Amid U.S. and China Weakness
Apple Explores India for iPhone Chip Assembly as Manufacturing Push Accelerates
FAA Unveils Flight Plan 2026 to Strengthen Aviation Safety and Workforce Development
Coca-Cola’s Proposed Sale of Costa Coffee Faces Uncertainty Amid Price Dispute
Fortescue Expands Copper Portfolio With Full Takeover of Alta Copper
noyb Files GDPR Complaints Against TikTok, Grindr, and AppsFlyer Over Alleged Illegal Data Tracking.
Blackstone Leads $400 Million Funding Round in Cyera at $9 Billion Valuation
Nomura Expands Alternative Assets Strategy With Focus on Private Debt Acquisitions
CMOC to Acquire Equinox Gold’s Brazilian Mines in $1 Billion Deal to Expand Precious Metals Portfolio
Sanofi’s Efdoralprin Alfa Gains EMA Orphan Status for Rare Lung Disease
Nvidia Weighs Expanding H200 AI Chip Production as China Demand Surges
Woolworths Faces Fresh Class Action Over Alleged Underpayments, Shares Slide
SpaceX Begins IPO Preparations as Wall Street Banks Line Up for Advisory Roles 



